ABU DHABI, UAE – The increasing strength and depth of Abu Dhabi’s tech ecosystem is a magnet for global innovators who can easily access the talent, networks and markets they need to thrive, said Abdulla Abdul Aziz Al Shamsi, Acting Director-General of Abu Dhabi Investment Office (ADIO) at an event.
The Abu Dhabi Investment Office (ADIO), during the event, announced its support for three innovative global companies as the UAE capital’s tech ecosystem begins 2023 in expansion mode.
ADIO’s support of Ubisoft, Insilico Medicine and the Applied AI Company (AAICO) will enhance Abu Dhabi’s tech R&D and operational capabilities, building tech talent and infrastructure to spur innovation across sectors.
“ADIO will work closely with Ubisoft, Insilico Medicine and AAICO to develop and commercialise new technology and products in the UAE that benefits the world,” said Al Shamsi.
The three companies are at the forefront of innovation in areas including artificial intelligence (AI) and gaming. Ubisoft is a leading creator, publisher and distributor of interactive entertainment and services. Insilico Medicine is a market leader in pharma technology that utilises AI for rapid drug discovery, synthesis and testing, while AAICO is a UK-based technology company focused on building products to automate and enhance mission critical processes within the health and safety sectors.
ADIO is providing comprehensive support and will work closely with each company to pioneer new technology and products in the UAE capital. The new partnerships boost the local innovation ecosystem, with ADIO supporting 12 tech companies over the last 12 months, including Noon, Siemens Energy, Liquidity Capital, Innovaccer and OurCrowd.
Ubisoft, headquartered in France, is one of the largest video gaming companies developing, publishing and distributing video games for consoles, PCs, and mobile. Ubisoft has been in Abu Dhabi for 10 years. The company has already developed, published and marketed several mobile games, with a new mobile game in development, from its gaming studio in Abu Dhabi which is now being established into a “Regional Hub” through its new offices in the Yas Creative Hub.
Insilico Medicine is a market leader in pharma technology that utilises AI for rapid drug discovery, synthesis and testing. Insilico Medicine has developed a full stack proprietary Pharma AI platform to rapidly discover drugs while decreasing R&D costs. Insilico Medicine has had success in delivering a pulmonary fibrosis drug to the clinical trial stage at record speed among other drugs in the pipeline that are in advanced stages of discovery. Insilico Medicine will be establishing its regional HQ in Abu Dhabi focused on R&D for its AI platform. The Abu Dhabi-based team will play a crucial role in patent applications and proprietary IP over the next four years.
AAICO is a leading technology company focused on building products to automate and enhance mission critical processes for the health and safety sectors. The company applies its proprietary AI platform to develop targeted machine learning-driven products which automate businesses involving manual or repetitive work, and position them for this new, AI-driven era.
AAICO established an ADGM-based entity in 2022 and will relocate its global HQ from London to Abu Dhabi. In 2023, AAICO’s international tech leadership team will help develop Abu Dhabi’s talent pool, thereby contributing to the expansion of Abu Dhabi’s tech ecosystem and the export of world-class AI products to the UK, North America and Europe. AAICO will also collaborate with Abu Dhabi-based universities, providing a range of tailored knowledge transfer initiatives, hackathons, exchange programmes, and internships. ADIO provides a range of support to innovation-led companies in high-growth areas including financial services, ICT, healthcare and biopharma, AgTech, tourism and more.